Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements Of Cash Flows

v3.22.1
Condensed Statements Of Cash Flows - USD ($)
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash flows from operating activities:    
Net loss $ (23,552,197) $ (732,339)
Adjustments to reconcile net loss to net cash used in operating activities:    
Interest income on cash and investments held in Trust Account (35,883) (1,444)
Offering costs allocated to derivative warrant liabilities 0 497,634
Change in fair value of derivative warrant liabilities (7,654,280) 208,793
Initial measurement of backstop derivative liability 30,234,314  
Changes in operating assets and liabilities:    
Prepaid assets 155,123 (1,244,423)
Accrued costs and expenses 395,513 1,266,779
Due to related party 30,000 0
Net cash used in operating activities (427,410) (5,000)
Cash flows from investing activity:    
Investment of cash in Trust Account (402,500,000) (350,000,000)
Net cash used in investing activity   (350,000,000)
Cash flows from financing activities:    
Proceeds from purchase of Class B shares by initial shareholder 0 25,000
Proceeds from initial public offering, net of underwriters' discount 0 343,000,000
Proceeds from private placement 0 9,000,000
Payment of offering costs 0 (595,525)
Net cash provided by financing activities 0 351,429,475
Net change in cash (427,410) 1,424,475
Cash, beginning of the period 507,233 0
Cash, end of the period 79,823 1,424,475
Supplemental disclosure of cash flow information:    
Deferred underwriting commissions charged to temporary equity $ 0 $ 12,250,000